Can Dementia And Other Neurodegenerative Disease Be Diagnosed With Blood Tests

1. Blood Tests Could Detect Neurodegenerative Diseases Blood tests could help detect neurodegenerative diseases. A medical transcription service company can provide documentation support for medical research. Medical Transcription Services United States 918-221-7809

2. Blood tests are an important way to diagnose various health conditions and accurate documentation is also indispensable. Physicians belonging to all medical specialties utilize documentation support provided by a medical transcription company to ensure accuracy and reliability of the medical record. As each speciality in the healthcare sector expands, new terminologies, techniques, studies and researches emerge which require error-free medical documentation. The following is one such significant research in the field of neurology. Researches show that every 3.2 seconds someone in the world is diagnosed with dementia. Around 46.8 million people live with dementia and it is estimated that by 2050 this will more than double to 152 million people. There is no cure for dementia. Diagnosis of dementia involves a series of tests that are complicated. A clinical assessment to diagnose Alzheimer's is a continuing process of elimination and involves a combination of tests, from cognitive screening, neuropsychological tests, brain imaging tests, genetic tests, spinal fluid tests and PET scans for amyloid. This becomes an obstacle for drug development and diagnosis. To find a cure for Alzheimer’s, healthcare researchers should know how effective drugs are in halting and reversing the disease. Co-founders of Esya Labs, Dhivya Venkat and Dr Yamuna Krishnan, professor of chemistry and brain research foundation fellow at the Grossman Institute of Neuroscience and Quantitative Biology at the University of Chicago, are working on how dementia and other neurodegenerative diseases can be diagnosed and treated. Their objective is to revolutionize the way neurodegenerative diseases such as dementia are currently diagnosed, building precision diagnostics using their breakthrough cell- scanning nanotechnology for early and accurate identification, well before the disease symptoms manifest physically. Now, Esya has pioneered a patented technology that is expected to be a game-changer in this area. How It Works With a simple blood test or skin biopsy, using their patented DNA devices, Esya Labs can measure and monitor disease progression for neurodegenerative diseases such as Alzheimer’s. They can also support pharmaceutical companies with drug development by evaluating patients’ response to specific treatments. Their patented nanodevices are in fact DNA filaments knitted together that hold measuring devices for specific chemicals. It can also be used to interrogate living cells to know how cells function. With the help of sensor technology Esya can setup non-invasive biomarkers to diagnose neurodegenerative diseases at the earliest stage. www.medicaltranscriptionservicecompany.com 918-221-7809

3. Divya Venkat says that an initial trial of Esya’s technology is all ready for lysosomal diseases and Alzheimer’s. They got outstanding results in their pilot program and can already see differences in patients who have manifested Alzheimer’s due to different genetic mutations. To include a larger sample size, they plan to expand. They are also building partnerships with Alzheimer’s drug discovery companies for utilization of their technology to support therapeutics development. EsyaLabs hopes that in three years from now they will be able to market their diagnosis biomarkers subject to all the relevant regulatory approvals. It is expected that Esya’s biomarkers will disrupt a market that is very much in need of precision diagnosis and drug discovery. Documentation is key when talking about neurology transcription for diseases such as dementia and Alzheimer’s. Accurate documentation of all healthcare details of patients can be ensured with reliable audio transcripts from an experienced medical transcription service company. This will help in improving patient care activities and will also support various research programs. www.medicaltranscriptionservicecompany.com 918-221-7809